The Use of ECMO in Pediatric Granulomatosis With Polyangiitis

Authors

Rachel Finkel, Department of Pediatrics, Maria Fareri Children's Hospital, Westchester Medical Center, New York Medical College, Valhalla, New York, USA.
Jesse Honig, Department of Pediatrics, New York Medical College, Valhalla, New York, USA.
Chun P. Chao, Division of Rheumatology, Maria Fareri Children's Hospital, Westchester Medical Center, Boston Children's Health Physicians, New York Medical College, Valhalla, New York, USA.Follow
Erin Rescoe, Division of Critical Care Medicine, Maria Fareri Children's Hospital, Westchester Medical Center, Boston Children's Health Physicians, New York Medical College, Valhalla, New York, USA.
Sonia Solomon, Division of Pediatric Nephrology, Maria Fareri Children's Hospital, Westchester Medical Center, Boston Children's Health Physicians, New York Medical College, Valhalla, NY, USA. ssolomon20@nymc.edu.Follow

Author Type(s)

Faculty

DOI

10.1186/s12969-022-00693-8

Journal Title

Pediatric Rheumatology Online Journal

First Page

35

Document Type

Article

Publication Date

5-10-2022

Department

Pediatrics

Abstract

BACKGROUND: Granulomatosis with polyangiitis (GPA) vasculitis with pulmonary-renal syndrome rarely presents in children and is associated with high mortality rates. CASE PRESENTATION: We present the case of a 13-year-old male with newly diagnosed GPA vasculitis, treated with extracorporeal membrane oxygenation, continuous renal replacement therapy, plasmapheresis, rituximab, cyclophosphamide, and corticosteroids. CONCLUSION: This case presentation demonstrates that ECMO can be used as a life supporting therapy in pediatric patients with pulmonary hemorrhage from ANCA vasculitis in conjunction with other therapies.

Recommended Citation

Finkel, R., Honig, J., Chao, C. P., Rescoe, E., & Solomon, S. (2022). The Use of ECMO in Pediatric Granulomatosis With Polyangiitis. Pediatric Rheumatology Online Journal, 20 (1), 35. https://doi.org/10.1186/s12969-022-00693-8